Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia
Condition: Atypical Ductal Hyperplasia Intervention: Device: Contrast enhanced mammography Sponsors: Dana-Farber Cancer Institute; GE Healthcare Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Mammography